Bed Bath And Beyond Is Getting Crushed

Bed, Bath & Beyond is down 11% to $70.81 after the company missed earnings and cut full-year guidance yesterday.

Analysts at Canaccord Genuity lowered their pre ice target to $73, from $84. Credit Suisse downgraded it to neutral and cut their price target from $85, to $78. And Oppenheimer lowered its price target to $86, reports 24/7 Wall Street.

The stock is said to have hit its short-sale circuit breaker, which puts a ban on short-selling after a stock has dropped a certain amount.